Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis-Reference-Cited by-同舟云学术

Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis

Published:2019-02-11 Issue:3 Volume:95 Page:329-337
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

Rim Chai Hong¹^ORCID,Kim Young²,Kim Chul Yong³,Yoon Won Sup¹,Yang Dae Sik⁴

Affiliation:

1. Department of Radiation Oncology, Ansan Hospital Korea University Medical College, Ansan, Republic of Korea;

2. Division of Pulmonary Sleep and Critical Care Medicine, Department of Internal Medicine, Ansan Hospital Korea University Medical College, Ansan, Republic of Korea;

3. Department of Radiation Oncology, Anam Hospital Korea University Medical College, Seoul, Republic of Korea;

4. Department of Radiation Oncology, Guro Hospital Korea University Medical College, Seoul, Republic of Korea

Funder

National research fund of Korea

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09553002.2019.1552375

Reference39 articles.

1. Traditional reviews, meta-analyses and pooled analyses in epidemiology

2. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

3. Prospective, Risk-Adapted Strategy of Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Trial

4. The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy;Radiotherapy and Oncology;2024-11

2. Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review;BMC Cancer;2024-07-10

3. Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC) Therapy;Cancer Research Journal;2024-06-19

4. Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central Lung Tumor;Medicina;2024-03-26

5. Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors;International Journal of Radiation Oncology*Biology*Physics;2023-12